Derivation of Double-Targeted Adenovirus Vectors for Gene Therapy of Prostate Cancer
Abstract
The subject of these studies is the development of targeted vector for selective infection and killing prostate cancer cells. The resultant vector is to be administered to prostate cancer patients to find, infect and destroy tumor cells. Targeting of the vector to prostate tumors is to be accomplished via incorporation into its capsid of ligands, which selectively bind to prostate-specific membrane antigen (PSMA).
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2005
- Accession Number
- ADA439290
Entities
People
- Victor Krasnykh
Organizations
- The University of Texas MD Anderson Cancer Center